COMMUNIQUÉS West-GlobeNewswire
-
Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR Amyloidosis Cardiomyopathy at the AHA 2018 Scientific Sessions in a Late-Breaking Featured Science Oral Presentation
05/10/2018 - 15:10 -
FSD Pharma Takes the Spotlight in CNBC's Cannabis Coverage -- CFN Media
05/10/2018 - 15:00 -
Medibio Provides Updated Company Presentation
05/10/2018 - 15:00 -
Chemesis Rolling Up High Value Cannabis Assets in United States -- CFN Media
05/10/2018 - 15:00 -
VPR Brands Showcasing its GOLDLINE Hemp Brand at NACS Expo in Las Vegas
05/10/2018 - 14:45 -
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program to Treat Charcot-Marie-Tooth (CMT) Neuropathy, Globally the Most Common Inherited Neuromuscular Disorder
05/10/2018 - 14:30 -
Agritek Holdings, Inc. Announces First Approved Hospitality Model And Full Service Wellness Resort As Cannabis Approaches Legalization In Canada This Month
05/10/2018 - 14:30 -
Veritas Signs MOU with Leader in Puerto Rico’s Medicinal Cannabis Market
05/10/2018 - 14:15 -
Histogenics Corporation Announces Pricing of Public Offering of Common Stock and Warrants
05/10/2018 - 14:10 -
Iterum Therapeutics Presents Data Highlighting Antibiotic Sulopenem at IDWeek 2018
05/10/2018 - 14:00 -
CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
05/10/2018 - 14:00 -
XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
05/10/2018 - 14:00 -
Melinta Therapeutics Publishes Findings from Orbactiv® (oritavancin) Real-World Registry Demonstrating Efficacy and Safety Consistent with Phase 3 SOLO Program
05/10/2018 - 14:00 -
Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
05/10/2018 - 13:30 -
BioCorRx to Exhibit at the International Association of Chiefs of Police 2018 Annual Conference in Orlando, Florida
05/10/2018 - 13:30 -
Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer
05/10/2018 - 13:30 -
Calithera Biosciences Highlights Breadth of Innovative Pipeline at R&D Day
05/10/2018 - 13:01 -
Chimerix Presents Results from Multiple Ascending Dose Study of IV Brincidofovir at IDWeek
05/10/2018 - 13:00 -
Protalix BioTherapeutics Presents Positive Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 1st Canadian Symposium on Lysosomal Diseases 2018
05/10/2018 - 13:00
Pages